BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
14,030
+30 (0.21%)
At close: Mar 6, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 116.61 billion as of March 9, 2026. Its market cap has decreased by -5.76% in one year.
Market Cap
116.61B
Enterprise Value
65.77B
Revenue
18.82B
Ranking
n/a
PE Ratio
16.14
Stock Price
14,030.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 116.61B, a decrease of -39.59%. That is a compound annual growth rate of -11.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 122.00B | -11.20% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 123.54B |
| NovMetaPharma | 117.37B |
| ViGenCell | 114.39B |
| IMGT Co.,Ltd. | 106.96B |
| Quratis | 103.62B |
| TegoScience | 103.44B |
| Progen | 100.55B |
| Cell Biotech | 96.29B |